Working… Menu
Trial record 1 of 1 for:    hector, topotecan
Previous Study | Return to List | Next Study

Hycamtin Plus Carboplatin Versus Established Regimens for the Treatment of Ovarian Cancer Relapse (HECTOR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00437307
Recruitment Status : Completed
First Posted : February 21, 2007
Last Update Posted : September 22, 2016
Information provided by (Responsible Party):
North Eastern German Society of Gynaecological Oncology

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 2013
Actual Study Completion Date : June 2015